Aristolochic acid A (150, 200 μM, 24?hours) inhibits the cell viabilities of kidney cells HEK293 and HK-2.
Aristolochic acid A (100, 200 μM, 24?hours) causes a concentration-dependent decrease in bladder cancer-associated protein (BLCAP) mRNA levels in kidney cells (HEK 293 and HK-2) , and bladder cancer cell line (HT-1376).
Aristolochic acid A (100, 200 μM, 24?hours) weakens the BLCAP protein signals in a dose-dependent manner in both HEK293 and HT-1376 cells.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line: |
Kidney cells (HEK 293 and HK-2) |
Concentration: |
50, 100, 150, 200 μM |
Incubation Time: |
24 hours |
Result: |
The cell viabilities of HEK293 and HK-2 were lower than that of vehicle-treated cultures until 150?μM and 200?μM. |
RT-PCR
Cell Line: |
Kidney cells (HEK 293 and HK-2), and bladder cancer cell line (HT-1376) |
Concentration: |
100, 200 μM |
Incubation Time: |
24 hours |
Result: |
Down regulated the levels of BLCAP mRNA. |
Western Blot Analysis
Cell Line: |
HEK293 and HT-1376 cells |
Concentration: |
100, 200 μM |
Incubation Time: |
24 hours |
Result: |
Reduced the BLCAP protein expression in a dose-dependent manner. |